Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain.

作者: D M McCord , D M Monroe , K J Smith , H R Roberts

DOI: 10.1016/S0021-9258(18)86939-3

关键词:

摘要: Factor IX Alabama is a factor variant in which glycine has been substituted for Asp47 the first epidermal growth (EGF) domain. The structural defect results molecule with 10% of normal coagulant activity. interactions immunoaffinity-purified its activator, cofactors, and substrate have investigated to determine functional variant. activated by XIa/calcium at near rates. Calcium fluorescence-quenching experiments indicate that high affinity calcium binding EGF domain not altered Alabama. active site IXa fully competent activate X absence when using polylysine as surface catalyze reaction. only 64% activity presence 300 microM CaCl2 polylysine-catalyzed system although apparent constants are similar. 52-60% calcium/phospholipid vesicle system. addition VIIIa phospholipid decreases relative rate 18-19% normal. Three-dimensional computer-aided models no major alterations resulting from substitution Asp47. model predicts calcium-binding involving Asp47, Asp49, Asp64, Asp65. Our data, however, necessary form site. We conclude coordinates bound calcium, inducing conformational change essential proper interaction VIIIa.

参考文章(42)
DM Monroe, DM McCord, MN Huang, KA High, RL Lundblad, CK Kasper, HR Roberts, Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo. Blood. ,vol. 73, pp. 1540- 1544 ,(1989) , 10.1182/BLOOD.V73.6.1540.1540
LM Davis, RA McGraw, JL Ware, HR Roberts, DW Stafford, Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B. Blood. ,vol. 69, pp. 140- 143 ,(1987) , 10.1182/BLOOD.V69.1.140.140
T Morita, B S Isaacs, C T Esmon, A E Johnson, Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid. Journal of Biological Chemistry. ,vol. 259, pp. 5698- 5704 ,(1984) , 10.1016/S0021-9258(18)91070-7
M J Griffith, C M Noyes, F C Church, Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. Journal of Biological Chemistry. ,vol. 260, pp. 2218- 2225 ,(1985) , 10.1016/S0021-9258(18)89541-2
C L Orthner, R D Madurawe, W H Velander, W N Drohan, F D Battey, D K Strickland, Conformational changes in an epitope localized to the NH2-terminal region of protein C. Evidence for interaction of protein C domains. Journal of Biological Chemistry. ,vol. 264, pp. 18781- 18788 ,(1989) , 10.1016/S0021-9258(18)51535-0
JN Lozier, DM Monroe, S Stanfield-Oakley, SW Lin, KJ Smith, HR Roberts, KA High, Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B Blood. ,vol. 75, pp. 1097- 1104 ,(1990) , 10.1182/BLOOD.V75.5.1097.BLOODJOURNAL7551097
E Persson, M Selander, S Linse, T Drakenberg, A K Ohlin, J Stenflo, Calcium binding to the isolated beta-hydroxyaspartic acid-containing epidermal growth factor-like domain of bovine factor X. Journal of Biological Chemistry. ,vol. 264, pp. 16897- 16904 ,(1989) , 10.1016/S0021-9258(19)84792-0
Claudia M. Noyes, Optimization of complex separations in high-performance liquid chromatography Journal of Chromatography A. ,vol. 266, pp. 451- 460 ,(1983) , 10.1016/S0021-9673(01)90916-1
P Fernlund, J Stenflo, Beta-hydroxyaspartic acid in vitamin K-dependent proteins. Journal of Biological Chemistry. ,vol. 258, pp. 12509- 12512 ,(1983) , 10.1016/S0021-9258(17)44205-0